Ontology type: schema:ScholarlyArticle Open Access: True
2017-06-05
AUTHORSS Tharkar-Promod, D P Johnson, S E Bennett, E M Dennis, B G Banowsky, S S Jones, J R Shearstone, S N Quayle, C Min, M Jarpe, T Mosbruger, A D Pomicter, R R Miles, W Y Chen, K N Bhalla, P A Zweidler-McKay, D C Shrieve, M W Deininger, M B Chandrasekharan, S Bhaskara
ABSTRACTPhiladelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic leukemia (ALL) expressing BCR-ABL1 oncoprotein is a major subclass of ALL with poor prognosis. BCR-ABL1-expressing leukemic cells are highly dependent on double-strand break (DSB) repair signals for their survival. Here we report that a first-in-class HDAC1,2 selective inhibitor and doxorubicin (a hyper-CVAD chemotherapy regimen component) impair DSB repair networks in Ph+ B-cell precursor ALL cells using common as well as distinct mechanisms. The HDAC1,2 inhibitor but not doxorubicin alters nucleosomal occupancy to impact chromatin structure, as revealed by MNase-Seq. Quantitative mass spectrometry of the chromatin proteome along with functional assays showed that the HDAC1,2 inhibitor and doxorubicin either alone or in combination impair the central hub of DNA repair, the Mre11–Rad51–DNA ligase 1 axis, involved in BCR-ABL1-specific DSB repair signaling in Ph+ B-cell precursor ALL cells. HDAC1,2 inhibitor and doxorubicin interfere with DISC (DNA damage-induced transcriptional silencing in cis)) or transcriptional silencing program in cis around DSB sites via chromatin remodeler-dependent and -independent mechanisms, respectively, to further impair DSB repair. HDAC1,2 inhibitor either alone or when combined with doxorubicin decreases leukemia burden in vivo in refractory Ph+ B-cell precursor ALL patient-derived xenograft mouse models. Overall, our novel mechanistic and preclinical studies together demonstrate that HDAC1,2 selective inhibition can overcome DSB repair ‘addiction’ and provide an effective therapeutic option for Ph+ B-cell precursor ALL. More... »
PAGES49-60
http://scigraph.springernature.com/pub.10.1038/leu.2017.174
DOIhttp://dx.doi.org/10.1038/leu.2017.174
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1085866068
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/28579617
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Animals",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Line, Tumor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "DNA Breaks, Double-Stranded",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "DNA Repair",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Doxorubicin",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Fusion Proteins, bcr-abl",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Histone Deacetylase 1",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Histone Deacetylase 2",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mice",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Philadelphia Chromosome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.479969.c",
"name": [
"Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Tharkar-Promod",
"givenName": "S",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.223827.e",
"name": [
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Johnson",
"givenName": "D P",
"id": "sg:person.01065034146.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065034146.30"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.479969.c",
"name": [
"Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Bennett",
"givenName": "S E",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.479969.c",
"name": [
"Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Dennis",
"givenName": "E M",
"id": "sg:person.01342641502.65",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342641502.65"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.479969.c",
"name": [
"Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Banowsky",
"givenName": "B G",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Regenacy Pharmaceuticals Inc., Boston, MA, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Acetylon Pharmaceuticals Inc., Boston, MA, USA",
"Regenacy Pharmaceuticals Inc., Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "Jones",
"givenName": "S S",
"id": "sg:person.07651557767.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07651557767.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Acetylon Pharmaceuticals Inc., Boston, MA, USA",
"id": "http://www.grid.ac/institutes/grid.427616.0",
"name": [
"Acetylon Pharmaceuticals Inc., Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "Shearstone",
"givenName": "J R",
"id": "sg:person.01355502635.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355502635.58"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Acetylon Pharmaceuticals Inc., Boston, MA, USA",
"id": "http://www.grid.ac/institutes/grid.427616.0",
"name": [
"Acetylon Pharmaceuticals Inc., Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "Quayle",
"givenName": "S N",
"id": "sg:person.01313157443.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313157443.42"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Acetylon Pharmaceuticals Inc., Boston, MA, USA",
"id": "http://www.grid.ac/institutes/grid.427616.0",
"name": [
"Acetylon Pharmaceuticals Inc., Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "Min",
"givenName": "C",
"id": "sg:person.01152042542.55",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152042542.55"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Regenacy Pharmaceuticals Inc., Boston, MA, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Regenacy Pharmaceuticals Inc., Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "Jarpe",
"givenName": "M",
"id": "sg:person.01301256505.44",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301256505.44"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.479969.c",
"name": [
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Mosbruger",
"givenName": "T",
"id": "sg:person.010235372427.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010235372427.52"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.479969.c",
"name": [
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Pomicter",
"givenName": "A D",
"id": "sg:person.01143025413.05",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143025413.05"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.223827.e",
"name": [
"Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Miles",
"givenName": "R R",
"id": "sg:person.01071621517.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071621517.50"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cancer Biology, City of Hope National Medical Center, Duarte, CA, USA",
"id": "http://www.grid.ac/institutes/grid.410425.6",
"name": [
"Department of Cancer Biology, City of Hope National Medical Center, Duarte, CA, USA"
],
"type": "Organization"
},
"familyName": "Chen",
"givenName": "W Y",
"id": "sg:person.013253670074.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013253670074.36"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Bhalla",
"givenName": "K N",
"id": "sg:person.0576206246.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576206246.42"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Zweidler-McKay",
"givenName": "P A",
"id": "sg:person.01234046364.17",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234046364.17"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.223827.e",
"name": [
"Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Shrieve",
"givenName": "D C",
"id": "sg:person.01127234221.59",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127234221.59"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.223827.e",
"name": [
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Deininger",
"givenName": "M W",
"id": "sg:person.01066552042.26",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066552042.26"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.479969.c",
"name": [
"Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Chandrasekharan",
"givenName": "M B",
"id": "sg:person.01262613325.91",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262613325.91"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA",
"id": "http://www.grid.ac/institutes/grid.223827.e",
"name": [
"Department of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA",
"Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA"
],
"type": "Organization"
},
"familyName": "Bhaskara",
"givenName": "S",
"id": "sg:person.01200120445.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200120445.09"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1186/1756-8935-6-27",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032233933",
"https://doi.org/10.1186/1756-8935-6-27"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.onc.1206087",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037121446",
"https://doi.org/10.1038/sj.onc.1206087"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/onc.2012.83",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040827860",
"https://doi.org/10.1038/onc.2012.83"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nsmb0809-798",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017148075",
"https://doi.org/10.1038/nsmb0809-798"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11912-012-0247-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050077877",
"https://doi.org/10.1007/s11912-012-0247-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/onc.2012.203",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035408028",
"https://doi.org/10.1038/onc.2012.203"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1631/jzus.b1400077",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020672616",
"https://doi.org/10.1631/jzus.b1400077"
],
"type": "CreativeWork"
}
],
"datePublished": "2017-06-05",
"datePublishedReg": "2017-06-05",
"description": "Philadelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic leukemia (ALL) expressing BCR-ABL1 oncoprotein is a major subclass of ALL with poor prognosis. BCR-ABL1-expressing leukemic cells are highly dependent on double-strand break (DSB) repair signals for their survival. Here we report that a first-in-class HDAC1,2 selective inhibitor and doxorubicin (a hyper-CVAD chemotherapy regimen component) impair DSB repair networks in Ph+ B-cell precursor ALL cells using common as well as distinct mechanisms. The HDAC1,2 inhibitor but not doxorubicin alters nucleosomal occupancy to impact chromatin structure, as revealed by MNase-Seq. Quantitative mass spectrometry of the chromatin proteome along with functional assays showed that the HDAC1,2 inhibitor and doxorubicin either alone or in combination impair the central hub of DNA repair, the Mre11\u2013Rad51\u2013DNA ligase 1 axis, involved in BCR-ABL1-specific DSB repair signaling in Ph+ B-cell precursor ALL cells. HDAC1,2 inhibitor and doxorubicin interfere with DISC (DNA damage-induced transcriptional silencing in cis)) or transcriptional silencing program in cis around DSB sites via chromatin remodeler-dependent and -independent mechanisms, respectively, to further impair DSB repair. HDAC1,2 inhibitor either alone or when combined with doxorubicin decreases leukemia burden in vivo in refractory Ph+ B-cell precursor ALL patient-derived xenograft mouse models. Overall, our novel mechanistic and preclinical studies together demonstrate that HDAC1,2 selective inhibition can overcome DSB repair \u2018addiction\u2019 and provide an effective therapeutic option for Ph+ B-cell precursor ALL.",
"genre": "article",
"id": "sg:pub.10.1038/leu.2017.174",
"inLanguage": "en",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.3933537",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.3625239",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1097065",
"issn": [
"0887-6924",
"1476-5551"
],
"name": "Leukemia",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "32"
}
],
"keywords": [
"DSB repair",
"DNA repair",
"B cell precursors",
"acute lymphoblastic leukemia",
"quantitative mass spectrometry",
"B-cell precursor acute lymphoblastic leukemia",
"chromatin proteome",
"chromatin structure",
"MNase-seq",
"DSB sites",
"nucleosomal occupancy",
"BCR-ABL1",
"repair signals",
"repair network",
"lymphoblastic leukemia",
"functional assays",
"patient-derived xenograft mouse models",
"central hub",
"distinct mechanisms",
"independent mechanisms",
"xenograft mouse model",
"effective therapeutic option",
"BCR-ABL1 oncoprotein",
"selective inhibitor",
"major subclasses",
"leukemia burden",
"therapeutic options",
"poor prognosis",
"inhibitors",
"cells",
"selective inhibition",
"preclinical studies",
"mouse model",
"leukemic cells",
"mass spectrometry",
"proteome",
"chromatin",
"repair",
"inhibition",
"leukemia",
"oncoprotein",
"precursors",
"mechanism",
"doxorubicin",
"assays",
"vivo",
"prognosis",
"occupancy",
"impairs",
"sites",
"survival",
"burden",
"hub",
"addiction",
"spectrometry",
"options",
"subclasses",
"signals",
"cis",
"study",
"structure",
"axis",
"program",
"class",
"network",
"disk",
"model"
],
"name": "HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia",
"pagination": "49-60",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1085866068"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/leu.2017.174"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"28579617"
]
}
],
"sameAs": [
"https://doi.org/10.1038/leu.2017.174",
"https://app.dimensions.ai/details/publication/pub.1085866068"
],
"sdDataset": "articles",
"sdDatePublished": "2022-06-01T22:18",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_743.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/leu.2017.174"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.174'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.174'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.174'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.174'
This table displays all metadata directly associated to this object as RDF triples.
378 TRIPLES
22 PREDICATES
115 URIs
99 LITERALS
21 BLANK NODES